Promising inhibition of diabetes-related enzymes and antioxidant properties of Ptilostemon casabonae leaves extract

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2274798. doi: 10.1080/14756366.2023.2274798. Epub 2023 Oct 31.

Abstract

Type 2 diabetes (T2D) is a progressive metabolic disorder of glucose metabolism. One of the therapeutic approaches for the treatment of T2D is reducing postprandial hyperglycaemia through inhibition of the digestive enzymes α-glucosidase and α-amylase. In this context, aimed at identifying natural products endowed with anti-T2D potential, we focused on Ptilostemon casabonae (L.) Greuter, a species belonging to Asteraceae family. Enzymatic inhibition, antioxidant activity, phenolic composition and cellular assays were performed. This study revealed that the P. casabonae hydroalcoholic extract exerts a potent inhibitory activity against α-glucosidase. This activity is supported by an antioxidant effect, preventing ROS formation in a stressed cellular system. HPLC-PDA-MS/MS analysis, revealed a complex polyphenolic fraction. Among the tested pure compounds, 1,5-dicaffeoylquinic acid, apigenin and rutin displayed good α-glucosidase inhibitory activity. Our study suggested new potential of P. casabonae encouraging us to further testing the possible therapeutic potential of this extract.

Keywords: Ptilostemon casabonae; diabetes; enzyme inhibition; α-Glucosidase; α-amylase.

MeSH terms

  • Antioxidants / pharmacology
  • Asteraceae*
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glycoside Hydrolase Inhibitors / pharmacology
  • Hypoglycemic Agents / pharmacology
  • Plant Extracts / pharmacology
  • Tandem Mass Spectrometry
  • alpha-Amylases / metabolism
  • alpha-Glucosidases / metabolism

Substances

  • Antioxidants
  • Hypoglycemic Agents
  • Glycoside Hydrolase Inhibitors
  • alpha-Glucosidases
  • Plant Extracts
  • alpha-Amylases

Grants and funding

This research was funded by Fondazione di Sardegna (2020), Project ID: F75F21001280007.